Clinical Prospects of NF-kB Inhibitors to Further Targeted Therapies in Rheumatology

Stefan K. Drexler, Jeremy J. O. Turner, Brian M. Foxwell

Research output: Chapter in Book/Report/Conference proceedingChapter


Many anti-inflammatory drugs currently used in clinical rheumatology are limited by lack of target specificity and a broad range of side effects consequent upon this. Thus, there is much interest in the possibility of developing improved targeted therapies that will have greater clinical efficacy combined with a narrower range of side effects.
Original languageEnglish
Title of host publicationContemporary Targeted Therapies in Rheumatology
EditorsPeter E. Lipsky, Josef S. Smolen
PublisherInforma Healthcare
Number of pages20
ISBN (Print)10: 1841844845
Publication statusPublished - 2007

Cite this